137 related articles for article (PubMed ID: 16914904)
1. Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival.
Keresztes K; Miltenyi Z; Bessenyei B; Beck Z; Szollosi Z; Nemes Z; Olah E; Illes A
Acta Haematol; 2006; 116(2):101-7. PubMed ID: 16914904
[TBL] [Abstract][Full Text] [Related]
2. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
3. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
4. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome.
Chabay PA; Barros MH; Hassan R; De Matteo E; Rey G; Carrico MK; Renault IZ; Preciado MV
J Pediatr Hematol Oncol; 2008 Apr; 30(4):285-91. PubMed ID: 18391697
[TBL] [Abstract][Full Text] [Related]
7. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
8. Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Assis MG; Eiras DP; Dobo C; Oliveira JS
Hematol Oncol; 2010 Sep; 28(3):137-41. PubMed ID: 20128016
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
10. Association of the Epstein-Barr viruses with Hodgkin lymphoma: an analysis of pediatric cases in Thailand.
Hemsrichart V; Pintong J
J Med Assoc Thai; 2005 Jun; 88(6):782-7. PubMed ID: 16083219
[TBL] [Abstract][Full Text] [Related]
11. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
12. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
13. [EBV-positive Hodgkin's lymphoma in children under 10 years].
Macák J; Plank L; Habanec B; Fabián P; Curík R; Nieslanik J; Bobot L; Vácha P; Utíkal Z; Dvorácková J
Vnitr Lek; 2000 Jul; 46(7):387-90. PubMed ID: 15635798
[TBL] [Abstract][Full Text] [Related]
14. Study of association of Epstein Barr-virus with Hodgkin's disease.
Radha K; Shanthi P; Madhavan M; Senthamarai A
Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
16. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
[TBL] [Abstract][Full Text] [Related]
17. Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic).
Macák J; Habanec B; Fabián P
Neoplasma; 2000; 47(3):156-61. PubMed ID: 11043838
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
Almasri NM; Khalidi HS
Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
[TBL] [Abstract][Full Text] [Related]
19. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
